These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 2627627)

  • 21. Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization.
    Mendoza-Maldonado R; Zentilin L; Fanin R; Giacca M
    Cancer Gene Ther; 2002 Jan; 9(1):71-86. PubMed ID: 11916246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E; Krahl R; Thalmeier K; Helbig W
    Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients.
    Hayette S; Michallet M; Baille ML; Magaud JP; Nicolini FE
    Leuk Res; 2005 Sep; 29(9):1073-7. PubMed ID: 16038734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression level of SH2 domain-containing protein tyrosine phosphatase-1 (Shp1) is associated with progression of chronic myeloid leukaemia.
    Amin HM; Hoshino K; Yang H; Lin Q; Lai R; Garcia-Manero G
    J Pathol; 2007 Aug; 212(4):402-10. PubMed ID: 17503411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An efficient laboratory made apparatus for DNA amplification.
    Bertrand O; Delfau MH; Garbarz M; Picat C; Devaux I; Dhermy D; Boivin P; Grandchamp B
    J Biochem Biophys Methods; 1989 May; 18(3):227-35. PubMed ID: 2732421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular detection of lymphoid-specific genetic markers in chronic myelogenous leukemia in chronic phase.
    Belessi C; Stamatopoulos K; Mantzourani M; Kosmas C; Loukopoulos D
    Leuk Res; 2000 Jun; 24(6):549-50. PubMed ID: 10905909
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of RNA concentration on cDNA synthesis for DNA amplification.
    Williams WV; Rosenbaum H; Weiner DB
    PCR Methods Appl; 1992 Aug; 2(1):86-8. PubMed ID: 1490179
    [No Abstract]   [Full Text] [Related]  

  • 30. [CML with mu-BCR/ABL mRNA: clinical characteristics of our three cases and 26 reported cases].
    Ito T
    Rinsho Ketsueki; 2003 Apr; 44(4):234-41. PubMed ID: 12784656
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular biology to check patients treated for CML.
    Saglio G; Zaccaria A; Tassinari A; Rosti G; Lo Coco F; Diverio D; Rege Cambrin G; Scaravaglio P; Rosso C; Guerrasio A
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():98-100. PubMed ID: 2627627
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The molecular biology diagnosis of neoplastic blood diseases].
    Teleheiev HD; Dybkov MV; Bozhko MV; Tretiak NM; Maliuta SS
    Tsitol Genet; 1998; 32(1):71-8. PubMed ID: 9695255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.